Cargando…
Colonic Perforation After Treatment With Nivolumab in Esophageal Cancer: A Case Report
With the advent of checkpoint inhibitors, it has opened up opportunities for numerous cancer patients. However, as is the case with every treatment, complications need to be weighed. Gastrointestinal adverse effects, such as diarrhea and colitis are well-known complications for checkpoint inhibitors...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Korean Society of Coloproctology
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8359691/ https://www.ncbi.nlm.nih.gov/pubmed/34167190 http://dx.doi.org/10.3393/ac.2020.00213.0030 |